Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention
Recruiting
Phase 4
Interventional Study
Deep Venous Thromboses
Laparotomy Patients
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 212 (estimated)
- Sponsor
- Mayo Hospital Lahore · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if rivaroxaban works better than enoxaparin to prevent deep vein thrombosis (DVT) after emergency exploratory laparotomy in adults. It will also learn about the safety of rivaroxaban compared to enoxaparin.
The main questions it aims to answer are:
Does rivaroxaban lower the number of patients who develop DVT after exploratory laparotomy compared to en…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:• Patients aged 18 to 80 years
* Both male or female patients
* Patients who have undergone emergent exploratory laparotomy for any reason whether traumatic or non-traumatic
* Patients with expected immobility for more than 24 hours
Exclusion Criteria:
* Patients with diagnosed…
Contacts